Duane Reade TRUEtrack monitor kit
Recall Z-1140-2013, part of FDA recall event 64499. See Nipro Diagnostics's company page.
Nipro Diagnostics, Inc. started this Class II device recall on Feb 25, 2013 (voluntary: firm initiated); FDA lists it as terminated, terminated Jul 8, 2013.
- Classification: Class II
- Started: Feb 25, 2013
- Status: Terminated
Meter kit outer boxes containing 10 ct. test strips state incorrect storage temperature range.
- Product
- Duane Reade TRUEtrack monitor kit, UPC# 6 39194 01679 7 Part # A4006-81 The TRUEtrack Blood Glucose System is intended for the quantitative determination of glucose in human whole blood taken from finger or forearm. The System is intended to be used to assist the patient and healthcare professional in the management of diabetes.
- Quantity
- 1,627 Kits
- Lots and codes
- Finished Good (FG) Kit Lot# KL01009-3TI, TRUEtrack Test Strip Lot# RL3435; FG Kit Lot# KL01009-12TI, TRUEtrack Test Strip Lot# RL3435; FG Kit Lot# KL01233-4TI, TRUEtrack Test Strip Lot# RL3476; FG Kit Lot# KM0548TI, TRUEtrack Test Strip Lot# RM3547; FG Kit Lot# KM0645TI, TRUEtrack Test Strip Lot# RM3562; FG Lot# KM0692TI, TRUEtrack Test Strip Lot# RM3562.
- Distribution
- Nationwide Distribution only in NY.
- Recalling firm
- Nipro Diagnostics, Inc., Ft Lauderdale, FL, United States
- How the firm notified
- Letter
- FDA classified
- Apr 18, 2013
Newest first, one product per recall event; search them all
- MooreMedical Supporting Health & Care...MooreBrand Blood Glucose Monitor for Self-Testing & Multi-Patient Use…Z-0909-2014 · Class II · Oct 2, 2013 · Terminated
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports